nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.221	1	CbGbCtD
Dobutamine—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.0134	0.0414	CcSEcCtD
Dobutamine—Masoprocol—IGF1R—type 2 diabetes mellitus	0.00719	0.334	CrCbGaD
Dobutamine—Angina pectoris—Repaglinide—type 2 diabetes mellitus	0.00696	0.0215	CcSEcCtD
Dobutamine—Angina pectoris—Pioglitazone—type 2 diabetes mellitus	0.00552	0.017	CcSEcCtD
Dobutamine—Thrombocytopenia—Tolbutamide—type 2 diabetes mellitus	0.00545	0.0168	CcSEcCtD
Dobutamine—Angina pectoris—Glimepiride—type 2 diabetes mellitus	0.00537	0.0166	CcSEcCtD
Dobutamine—Fenoterol—ADRB3—type 2 diabetes mellitus	0.00526	0.244	CrCbGaD
Dobutamine—Palpitations—Nateglinide—type 2 diabetes mellitus	0.00508	0.0157	CcSEcCtD
Dobutamine—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.00496	0.0153	CcSEcCtD
Dobutamine—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.00496	0.0153	CcSEcCtD
Dobutamine—Arbutamine—ADRB3—type 2 diabetes mellitus	0.00492	0.228	CrCbGaD
Dobutamine—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.00477	0.0147	CcSEcCtD
Dobutamine—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.00462	0.0143	CcSEcCtD
Dobutamine—Palpitations—Repaglinide—type 2 diabetes mellitus	0.0044	0.0136	CcSEcCtD
Dobutamine—Chest pain—Repaglinide—type 2 diabetes mellitus	0.00424	0.0131	CcSEcCtD
Dobutamine—Angina pectoris—Gliclazide—type 2 diabetes mellitus	0.00398	0.0123	CcSEcCtD
Dobutamine—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.00398	0.0123	CcSEcCtD
Dobutamine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00394	0.0122	CcSEcCtD
Dobutamine—CA5A—liver—type 2 diabetes mellitus	0.00394	0.0867	CbGeAlD
Dobutamine—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.00391	0.0121	CcSEcCtD
Dobutamine—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00376	0.0116	CcSEcCtD
Dobutamine—Nausea—Miglitol—type 2 diabetes mellitus	0.00368	0.0114	CcSEcCtD
Dobutamine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00359	0.0111	CcSEcCtD
Dobutamine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00359	0.0111	CcSEcCtD
Dobutamine—Labetalol—ADRB3—type 2 diabetes mellitus	0.00349	0.162	CrCbGaD
Dobutamine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00349	0.0108	CcSEcCtD
Dobutamine—Palpitations—Glimepiride—type 2 diabetes mellitus	0.0034	0.0105	CcSEcCtD
Dobutamine—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.0034	0.0105	CcSEcCtD
Dobutamine—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.00336	0.0104	CcSEcCtD
Dobutamine—Angina pectoris—Metformin—type 2 diabetes mellitus	0.00333	0.0103	CcSEcCtD
Dobutamine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00332	0.0102	CcSEcCtD
Dobutamine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00331	0.0102	CcSEcCtD
Dobutamine—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.00329	0.0102	CcSEcCtD
Dobutamine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00317	0.0098	CcSEcCtD
Dobutamine—Headache—Tolazamide—type 2 diabetes mellitus	0.00317	0.0098	CcSEcCtD
Dobutamine—COMT—islet of Langerhans—type 2 diabetes mellitus	0.00314	0.0692	CbGeAlD
Dobutamine—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.00314	0.0097	CcSEcCtD
Dobutamine—Headache—Linagliptin—type 2 diabetes mellitus	0.00314	0.00969	CcSEcCtD
Dobutamine—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00307	0.00948	CcSEcCtD
Dobutamine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00306	0.00945	CcSEcCtD
Dobutamine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00301	0.00929	CcSEcCtD
Dobutamine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00301	0.00929	CcSEcCtD
Dobutamine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.003	0.00925	CcSEcCtD
Dobutamine—Angina pectoris—Losartan—type 2 diabetes mellitus	0.00296	0.00912	CcSEcCtD
Dobutamine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00293	0.00905	CcSEcCtD
Dobutamine—Nausea—Acarbose—type 2 diabetes mellitus	0.00289	0.00892	CcSEcCtD
Dobutamine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00287	0.00887	CcSEcCtD
Dobutamine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00287	0.00886	CcSEcCtD
Dobutamine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.0028	0.00863	CcSEcCtD
Dobutamine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00279	0.0086	CcSEcCtD
Dobutamine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00276	0.00852	CcSEcCtD
Dobutamine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00272	0.00838	CcSEcCtD
Dobutamine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00264	0.00816	CcSEcCtD
Dobutamine—Headache—Repaglinide—type 2 diabetes mellitus	0.00255	0.00785	CcSEcCtD
Dobutamine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.00254	0.00782	CcSEcCtD
Dobutamine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00253	0.00782	CcSEcCtD
Dobutamine—COMT—nephron tubule—type 2 diabetes mellitus	0.00253	0.0558	CbGeAlD
Dobutamine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00252	0.00779	CcSEcCtD
Dobutamine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00252	0.00776	CcSEcCtD
Dobutamine—CA5B—cardiovascular system—type 2 diabetes mellitus	0.00247	0.0544	CbGeAlD
Dobutamine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00242	0.00748	CcSEcCtD
Dobutamine—Hypotension—Glyburide—type 2 diabetes mellitus	0.00242	0.00746	CcSEcCtD
Dobutamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00241	0.00745	CcSEcCtD
Dobutamine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00241	0.00742	CcSEcCtD
Dobutamine—CA5B—pancreas—type 2 diabetes mellitus	0.0024	0.0528	CbGeAlD
Dobutamine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00238	0.00734	CcSEcCtD
Dobutamine—Palpitations—Valsartan—type 2 diabetes mellitus	0.00231	0.00713	CcSEcCtD
Dobutamine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00231	0.00712	CcSEcCtD
Dobutamine—Palpitations—Orlistat—type 2 diabetes mellitus	0.00228	0.00705	CcSEcCtD
Dobutamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00228	0.00704	CcSEcCtD
Dobutamine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00227	0.00702	CcSEcCtD
Dobutamine—COMT—cardiovascular system—type 2 diabetes mellitus	0.00227	0.0501	CbGeAlD
Dobutamine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00227	0.007	CcSEcCtD
Dobutamine—Chest pain—Valsartan—type 2 diabetes mellitus	0.00223	0.00687	CcSEcCtD
Dobutamine—COMT—kidney—type 2 diabetes mellitus	0.00222	0.049	CbGeAlD
Dobutamine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00222	0.00685	CcSEcCtD
Dobutamine—COMT—pancreas—type 2 diabetes mellitus	0.00221	0.0487	CbGeAlD
Dobutamine—Chest pain—Orlistat—type 2 diabetes mellitus	0.0022	0.00679	CcSEcCtD
Dobutamine—CA5B—adipose tissue—type 2 diabetes mellitus	0.00218	0.0479	CbGeAlD
Dobutamine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00217	0.0067	CcSEcCtD
Dobutamine—COMT—cortex of kidney—type 2 diabetes mellitus	0.00217	0.0477	CbGeAlD
Dobutamine—Headache—Glipizide—type 2 diabetes mellitus	0.00211	0.0065	CcSEcCtD
Dobutamine—Palpitations—Metformin—type 2 diabetes mellitus	0.0021	0.00649	CcSEcCtD
Dobutamine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00209	0.00645	CcSEcCtD
Dobutamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00207	0.00639	CcSEcCtD
Dobutamine—Chest pain—Metformin—type 2 diabetes mellitus	0.00203	0.00626	CcSEcCtD
Dobutamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00202	0.00623	CcSEcCtD
Dobutamine—COMT—adipose tissue—type 2 diabetes mellitus	0.002	0.0442	CbGeAlD
Dobutamine—Nausea—Glipizide—type 2 diabetes mellitus	0.002	0.00616	CcSEcCtD
Dobutamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00199	0.00615	CcSEcCtD
Dobutamine—Headache—Glimepiride—type 2 diabetes mellitus	0.00197	0.00606	CcSEcCtD
Dobutamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00196	0.00605	CcSEcCtD
Dobutamine—CA2—islet of Langerhans—type 2 diabetes mellitus	0.00195	0.043	CbGeAlD
Dobutamine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.00193	0.0424	CbGeAlD
Dobutamine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00191	0.0059	CcSEcCtD
Dobutamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.0019	0.00587	CcSEcCtD
Dobutamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.0019	0.00587	CcSEcCtD
Dobutamine—Palpitations—Losartan—type 2 diabetes mellitus	0.00187	0.00577	CcSEcCtD
Dobutamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00186	0.00575	CcSEcCtD
Dobutamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00186	0.00573	CcSEcCtD
Dobutamine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00183	0.00565	CcSEcCtD
Dobutamine—Hypotension—Metformin—type 2 diabetes mellitus	0.00182	0.0056	CcSEcCtD
Dobutamine—Chest pain—Losartan—type 2 diabetes mellitus	0.0018	0.00556	CcSEcCtD
Dobutamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.0018	0.00554	CcSEcCtD
Dobutamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00179	0.00552	CcSEcCtD
Dobutamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00177	0.00547	CcSEcCtD
Dobutamine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00173	0.00535	CcSEcCtD
Dobutamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00171	0.00529	CcSEcCtD
Dobutamine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.0017	0.0374	CbGeAlD
Dobutamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00169	0.00522	CcSEcCtD
Dobutamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.00168	0.0052	CcSEcCtD
Dobutamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00168	0.00519	CcSEcCtD
Dobutamine—CA2—retina—type 2 diabetes mellitus	0.00167	0.0368	CbGeAlD
Dobutamine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00164	0.00507	CcSEcCtD
Dobutamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00164	0.00505	CcSEcCtD
Dobutamine—Headache—Glyburide—type 2 diabetes mellitus	0.00162	0.005	CcSEcCtD
Dobutamine—Hypotension—Losartan—type 2 diabetes mellitus	0.00161	0.00498	CcSEcCtD
Dobutamine—Palpitations—Ramipril—type 2 diabetes mellitus	0.0016	0.00495	CcSEcCtD
Dobutamine—CA2—nephron tubule—type 2 diabetes mellitus	0.00157	0.0346	CbGeAlD
Dobutamine—Chest pain—Ramipril—type 2 diabetes mellitus	0.00154	0.00476	CcSEcCtD
Dobutamine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00154	0.00475	CcSEcCtD
Dobutamine—Nausea—Glyburide—type 2 diabetes mellitus	0.00154	0.00474	CcSEcCtD
Dobutamine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00151	0.00466	CcSEcCtD
Dobutamine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00149	0.0046	CcSEcCtD
Dobutamine—Headache—Gliclazide—type 2 diabetes mellitus	0.00146	0.00449	CcSEcCtD
Dobutamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00145	0.00447	CcSEcCtD
Dobutamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00144	0.00446	CcSEcCtD
Dobutamine—CA2—cardiovascular system—type 2 diabetes mellitus	0.00141	0.0311	CbGeAlD
Dobutamine—COMT—liver—type 2 diabetes mellitus	0.00141	0.031	CbGeAlD
Dobutamine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00138	0.00427	CcSEcCtD
Dobutamine—CA2—kidney—type 2 diabetes mellitus	0.00138	0.0304	CbGeAlD
Dobutamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00138	0.00426	CcSEcCtD
Dobutamine—Pruritus—Metformin—type 2 diabetes mellitus	0.00138	0.00424	CcSEcCtD
Dobutamine—CA2—pancreas—type 2 diabetes mellitus	0.00137	0.0302	CbGeAlD
Dobutamine—CA2—cortex of kidney—type 2 diabetes mellitus	0.00135	0.0297	CbGeAlD
Dobutamine—Headache—Valsartan—type 2 diabetes mellitus	0.00134	0.00413	CcSEcCtD
Dobutamine—Headache—Orlistat—type 2 diabetes mellitus	0.00132	0.00408	CcSEcCtD
Dobutamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00132	0.00407	CcSEcCtD
Dobutamine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.0013	0.004	CcSEcCtD
Dobutamine—Nausea—Valsartan—type 2 diabetes mellitus	0.00127	0.00391	CcSEcCtD
Dobutamine—Nausea—Orlistat—type 2 diabetes mellitus	0.00125	0.00387	CcSEcCtD
Dobutamine—CA2—adipose tissue—type 2 diabetes mellitus	0.00125	0.0274	CbGeAlD
Dobutamine—Pruritus—Losartan—type 2 diabetes mellitus	0.00122	0.00377	CcSEcCtD
Dobutamine—Headache—Metformin—type 2 diabetes mellitus	0.00122	0.00376	CcSEcCtD
Dobutamine—Nausea—Metformin—type 2 diabetes mellitus	0.00115	0.00356	CcSEcCtD
Dobutamine—Headache—Irbesartan—type 2 diabetes mellitus	0.00115	0.00355	CcSEcCtD
Dobutamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.00109	0.00336	CcSEcCtD
Dobutamine—Headache—Losartan—type 2 diabetes mellitus	0.00108	0.00334	CcSEcCtD
Dobutamine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00105	0.00323	CcSEcCtD
Dobutamine—Nausea—Losartan—type 2 diabetes mellitus	0.00103	0.00316	CcSEcCtD
Dobutamine—Headache—Ramipril—type 2 diabetes mellitus	0.000927	0.00286	CcSEcCtD
Dobutamine—Nausea—Ramipril—type 2 diabetes mellitus	0.000879	0.00271	CcSEcCtD
Dobutamine—CA2—liver—type 2 diabetes mellitus	0.000873	0.0192	CbGeAlD
Dobutamine—Dopamine—CYP1A2—type 2 diabetes mellitus	0.000695	0.0323	CrCbGaD
Dobutamine—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	9.71e-05	0.00025	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.68e-05	0.00025	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARA—type 2 diabetes mellitus	9.68e-05	0.000249	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.64e-05	0.000248	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOB—type 2 diabetes mellitus	9.61e-05	0.000248	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.61e-05	0.000248	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.61e-05	0.000248	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.57e-05	0.000247	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	9.52e-05	0.000245	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.48e-05	0.000244	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.47e-05	0.000244	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.45e-05	0.000244	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.43e-05	0.000243	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.43e-05	0.000243	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.4e-05	0.000242	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AGT—type 2 diabetes mellitus	9.37e-05	0.000242	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.36e-05	0.000241	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTM1—type 2 diabetes mellitus	9.35e-05	0.000241	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.28e-05	0.000239	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.26e-05	0.000239	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.25e-05	0.000238	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.23e-05	0.000238	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CALM1—type 2 diabetes mellitus	9.21e-05	0.000238	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOE—type 2 diabetes mellitus	9.18e-05	0.000237	CbGpPWpGaD
Dobutamine—COMT—Metabolism—LPL—type 2 diabetes mellitus	9.18e-05	0.000237	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOA1—type 2 diabetes mellitus	9.08e-05	0.000234	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.05e-05	0.000233	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TLE4—type 2 diabetes mellitus	9e-05	0.000232	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ADCY5—type 2 diabetes mellitus	8.99e-05	0.000232	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GPX1—type 2 diabetes mellitus	8.96e-05	0.000231	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	8.88e-05	0.000229	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.81e-05	0.000227	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.75e-05	0.000226	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CD36—type 2 diabetes mellitus	8.72e-05	0.000225	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.67e-05	0.000223	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPP2CA—type 2 diabetes mellitus	8.61e-05	0.000222	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.61e-05	0.000222	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.56e-05	0.000221	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.48e-05	0.000219	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.42e-05	0.000217	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.37e-05	0.000216	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.31e-05	0.000214	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—type 2 diabetes mellitus	8.27e-05	0.000213	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.2e-05	0.000211	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.19e-05	0.000211	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.13e-05	0.00021	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARA—type 2 diabetes mellitus	8.11e-05	0.000209	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.02e-05	0.000207	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—type 2 diabetes mellitus	8e-05	0.000206	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AGT—type 2 diabetes mellitus	7.85e-05	0.000202	CbGpPWpGaD
Dobutamine—CA2—Metabolism—INS—type 2 diabetes mellitus	7.84e-05	0.000202	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.8e-05	0.000201	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.72e-05	0.000199	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CALM1—type 2 diabetes mellitus	7.72e-05	0.000199	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOE—type 2 diabetes mellitus	7.69e-05	0.000198	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.66e-05	0.000197	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.66e-05	0.000197	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.63e-05	0.000197	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOA1—type 2 diabetes mellitus	7.61e-05	0.000196	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.56e-05	0.000195	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.55e-05	0.000194	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.49e-05	0.000193	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.49e-05	0.000193	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.46e-05	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.46e-05	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.44e-05	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.44e-05	0.000192	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.41e-05	0.000191	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.38e-05	0.00019	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.34e-05	0.000189	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.3e-05	0.000188	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.3e-05	0.000188	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.28e-05	0.000188	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.28e-05	0.000188	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.24e-05	0.000187	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—type 2 diabetes mellitus	7.19e-05	0.000185	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.18e-05	0.000185	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.08e-05	0.000183	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.97e-05	0.00018	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.93e-05	0.000179	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.88e-05	0.000177	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NOS3—type 2 diabetes mellitus	6.88e-05	0.000177	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.82e-05	0.000176	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.81e-05	0.000176	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.72e-05	0.000173	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—type 2 diabetes mellitus	6.7e-05	0.000173	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.66e-05	0.000172	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.65e-05	0.000171	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.61e-05	0.00017	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.58e-05	0.00017	CbGpPWpGaD
Dobutamine—COMT—Metabolism—INS—type 2 diabetes mellitus	6.57e-05	0.000169	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.57e-05	0.000169	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.5e-05	0.000168	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.47e-05	0.000167	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.46e-05	0.000167	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.45e-05	0.000166	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.45e-05	0.000166	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.43e-05	0.000166	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.42e-05	0.000165	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.33e-05	0.000163	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.33e-05	0.000163	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.31e-05	0.000163	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.3e-05	0.000163	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	6.29e-05	0.000162	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.28e-05	0.000162	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.19e-05	0.00016	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	6.18e-05	0.000159	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.14e-05	0.000158	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.05e-05	0.000156	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—type 2 diabetes mellitus	6.03e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.01e-05	0.000155	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.98e-05	0.000154	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.96e-05	0.000154	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.96e-05	0.000154	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.88e-05	0.000151	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.85e-05	0.000151	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.83e-05	0.00015	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.83e-05	0.00015	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.8e-05	0.00015	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.78e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.78e-05	0.000149	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3R1—type 2 diabetes mellitus	5.76e-05	0.000149	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NOS3—type 2 diabetes mellitus	5.76e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.75e-05	0.000148	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.68e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.68e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.65e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.65e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.65e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.65e-05	0.000146	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.58e-05	0.000144	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.55e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.53e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.53e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.46e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.43e-05	0.00014	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.31e-05	0.000137	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—type 2 diabetes mellitus	5.27e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.26e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.24e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.17e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.17e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.15e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.12e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.09e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.07e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.06e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.06e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.98e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.96e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.84e-05	0.000125	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	4.78e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.75e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.75e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.73e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.65e-05	0.00012	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.65e-05	0.00012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.5e-05	0.000116	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	4.46e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.46e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.4e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.4e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.4e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.38e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.31e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.3e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.3e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.28e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.26e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.25e-05	0.00011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.23e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.22e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.18e-05	0.000108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.16e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.14e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.09e-05	0.000105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.06e-05	0.000105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.97e-05	0.000102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.97e-05	0.000102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.89e-05	0.0001	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.81e-05	9.81e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.74e-05	9.64e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.72e-05	9.6e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.66e-05	9.43e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.65e-05	9.42e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.57e-05	9.21e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.48e-05	8.98e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.48e-05	8.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.47e-05	8.95e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.41e-05	8.8e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.41e-05	8.79e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.4e-05	8.77e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.4e-05	8.77e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.4e-05	8.76e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.4e-05	8.75e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.36e-05	8.67e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.34e-05	8.61e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.33e-05	8.58e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.33e-05	8.58e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.29e-05	8.48e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.21e-05	8.27e-05	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—type 2 diabetes mellitus	3.16e-05	8.15e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.14e-05	8.09e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.03e-05	7.82e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.97e-05	7.65e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.91e-05	7.49e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.86e-05	7.37e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.84e-05	7.33e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.81e-05	7.25e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.81e-05	7.24e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.8e-05	7.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.8e-05	7.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.75e-05	7.09e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.75e-05	7.08e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.74e-05	7.05e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.67e-05	6.88e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—type 2 diabetes mellitus	2.65e-05	6.83e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.61e-05	6.73e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.55e-05	6.57e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.55e-05	6.57e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.49e-05	6.43e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.49e-05	6.43e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.4e-05	6.18e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.35e-05	6.05e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.18e-05	5.63e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.16e-05	5.58e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.15e-05	5.54e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.14e-05	5.51e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.12e-05	5.46e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.1e-05	5.42e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.04e-05	5.27e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.02e-05	5.21e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2e-05	5.16e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.98e-05	5.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.98e-05	5.1e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.94e-05	5e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.88e-05	4.86e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.84e-05	4.75e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.84e-05	4.73e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.8e-05	4.63e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.69e-05	4.34e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.65e-05	4.26e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.65e-05	4.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.62e-05	4.17e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.27e-05	3.27e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.24e-05	3.2e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.17e-05	3.02e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.15e-05	2.95e-05	CbGpPWpGaD
